USD 7.94
(2.98%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 94.76 Million USD | -45.82% |
2022 | 116.76 Million USD | 11.94% |
2021 | 104.31 Million USD | 17.9% |
2020 | 88.47 Million USD | 28.45% |
2019 | 68.88 Million USD | 24.46% |
2018 | 55.34 Million USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 23.49 Million USD | 131.92% |
2024 Q3 | 22.69 Million USD | -3.41% |
2024 Q1 | 10.13 Million USD | -34.97% |
2023 Q3 | 21.46 Million USD | -11.31% |
2023 FY | 63.26 Million USD | -45.82% |
2023 Q1 | 25.24 Million USD | -24.81% |
2023 Q2 | 24.2 Million USD | -4.14% |
2023 Q4 | 15.57 Million USD | -27.43% |
2022 Q2 | 28.01 Million USD | 2.01% |
2022 Q1 | 27.46 Million USD | -5.46% |
2022 Q3 | 27.7 Million USD | -1.13% |
2022 Q4 | 33.58 Million USD | 21.22% |
2022 FY | 116.76 Million USD | 11.94% |
2021 Q2 | 26.32 Million USD | 20.25% |
2021 Q4 | 29.05 Million USD | 7.45% |
2021 Q3 | 27.03 Million USD | 2.7% |
2021 FY | 104.31 Million USD | 17.9% |
2021 Q1 | 21.89 Million USD | -3.17% |
2020 FY | 88.47 Million USD | 28.45% |
2020 Q4 | 22.61 Million USD | 10.65% |
2020 Q3 | 20.43 Million USD | -17.41% |
2020 Q2 | 24.74 Million USD | 19.6% |
2020 Q1 | 20.68 Million USD | 2.84% |
2019 FY | 68.88 Million USD | 24.46% |
2019 Q4 | 20.11 Million USD | 28.26% |
2019 Q3 | 15.68 Million USD | -12.96% |
2019 Q2 | 18.01 Million USD | 19.63% |
2019 Q1 | 15.06 Million USD | 0.0% |
2018 FY | 55.34 Million USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Doximity, Inc. | 424.75 Million USD | 77.691% |
Evolent Health, Inc. | 460.47 Million USD | 79.421% |
MultiPlan Corporation | 306.03 Million USD | 69.037% |
Phreesia, Inc. | 201.74 Million USD | 53.03% |
Teladoc Health, Inc. | 1.84 Billion USD | 94.857% |
Veeva Systems Inc. | 1.68 Billion USD | 94.381% |